News
In this retrospective study, patients who started a GLP-1 agonist experienced significant declines in hidradenitis ...
One study found a modest risk of developing non-arteritic anterior ischaemic optic neuropathy (NAOIN), a rare eye condition ...
Company plans rapid advancement of semaglutide implant NPM-139, following positive weight loss data from an ongoing ...
Compelling new ARD-201 preclinical data informs optimized Phase 2 clinical development strategy of obesity programs: Phase 2 POWER trial of oral ARD-201 to focus on weight rebound in patients ...
Oikos Fusion offers a nutrient-dense dairy drink designed to support muscle mass and digestive health during weight loss ...
Texas has sued pharmaceutical giant Eli Lilly for allegedly bribing and illegally inducing medical providers to prescribe its ...
SHREVEPORT, La. - A new drug developed by Eli Lily works in a unique way compared to treatments already on the market, like ...
Last and least, I look at the drug stocks and I can’t believe how awful they really are, with now Eli Lilly last joining the ...
This Is Us star Chrissy Metz reflects on her struggles with her body image and self-worth, and shares her thoughts on weight ...
Insurance companies are increasingly restricting coverage for GLP-1 medications, impacting patient access and affordability.
The Hunting Wives' actress Chrissy Metz gets candid in a new cover story for PEOPLE on her thoughts about using weight loss ...
Novo Nordisk faces challenges but offers growth potential through a weight loss pill and global expansion. Read more on why ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results